Bipolar Disorder Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2940 | Report Format : | Status : Upcoming |

Abstract

Global Bipolar Disorder Market: Overview

Bipolar disorder is usually recognized as manic depression, it is a kind of mental illness which is mainly categorized by mood swings. Mood episodes are basically of two types: depressive and manic episodes. The changes or transformation in the mental condition can bring out sudden low or high moods in an individual. An individual who is suffering from bipolar disorder might be joyful, happy, and energized at a meticulous moment and may also be hopeless, sad, and lethargic at the next moment.

Global Bipolar Disorder Market: Growth Factors

The global bipolar disorder market is likely to be driven by the augment in the occurrence of bipolar disorder, several government initiatives to boost public knowledge about the effects of bipolar disorders, need to decrease the disease burden of bipolar disorder, and high demand and requirement for anti-depressants. On the other hand, the dearth of exact diagnostic methods for the identification of the syndrome/disorder as well as the side effects related to bipolar disorder is projected to hinder the market development. On the contrary, a development which is associated with combination therapies of medicines will offer lucrative prospects for the market development in the coming future.

Global Bipolar Disorder Market: Segmentation

The global bipolar disorder market is categorized in terms of types of bipolar disorder, mechanism of action, drug class, and region. In terms of bipolar disorder types, the market is fragmented into bipolar I disorder, it is a mixed or manic episode; bipolar II disorder, it is depression and hypomania; and cyclothymia, it is mild depression and hypomania. In terms of drug class, the global bipolar disorder market is divided into anticonvulsants, mood stabilizers, antidepressants, antipsychotics, and anti-anxiety drugs. Based on the mechanism of action, the global market is classified into serotonin-norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants, beta blockers, benzodiazepines, and others.

Global Bipolar Disorder Market: Regional Analysis

In terms of region, the global bipolar market is classified into the Middle East & Africa, Europe, North America, Latin America, and the Asia Pacific. North America is projected to dominate and lead the global bipolar disorder market owing to augmented knowledge and larger accessibility of treatment alternatives. The U.S. is likely to have a significant market share based on revenue, which is expected to be followed by Canada. Europe is likely to be the second dominating region, which is projected to contribute to the development of the global bipolar disorder market based on revenue, along with Germany and the U.K., having a significant market share of the global market. The Asia Pacific is expected to be the extremely prospective market with developing countries such as China and India. Augment in knowledge about the syndromes in the emerging countries is anticipated to fuel and contribute to the expansion of the global market owing to growing economy and increasing knowledge about the mental sickness.

Global Bipolar Disorder Market: Competitive Players

Some of the most important market players in the global bipolar disorder market are AstraZeneca., Pfizer Inc., Glaxo SmithKline (GSK), Eli Lilly, Janssen Pharmaceuticals, Novartis AG, Allergan Plc., Otsuka Holdings Co. Ltd., and AbbVie Inc., among others.

Global Bipolar Disorder Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Peptide and Anticoagulant Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3130 | Report Format:

Global Peptide and Anticoagulant Drugs Market: Overview Peptides anticoagulant drugs are likely to have a wide range of applications in treating several diseases for example osteoporosis, cancer, cardiovascular, diabetes, and coagulation disorders. Peptides are basically molecules that are univ...Read More

Crohn’s Disease Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3033 | Report Format:

Global Crohns Disease Market: Overview An inflammatory disease of bowel affecting any part of the Gastro-Intestinal Tract (GI Tract) is termed as Crohns disease. It is classified into a segment of chronic disease. Crohns disease is considered to impact nearly every part of an individuals life, a...Read More

Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3024 | Report Format:

Global Anti-Neoplastic Agents Market: Overview Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of canc...Read More

Kidney Fibrosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2989 | Report Format:

Global Kidney Fibrosis Treatment Market: Overview Fibrosis is the growth of extreme connective tissue owing to some injury or some disease. Disease in the kidney can cause kidney fibrosis. In this state, the kidneys fail to work properly which gradually leads to severe conditions. Kidney transpl...Read More

Oncology Based In-vivo CRO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2982 | Report Format:

Global Oncology Based In-vivo CRO Market: Overview CRO basically stands for contract research organization which presents research services to a pharmaceutical, biotechnology, and medical devices key players on the basis of the contract. CRO offers services such as clinical research, biologic as...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.